Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Form 8.3 - BLANCCO TECHNOLOGY GROUP PLC Amend

17 Oct 2023 11:14

RNS Number : 4076Q
Barclays PLC
17 October 2023
Β 

FORM 8.3 Amendment to Purchase

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and shortΒ positions disclosed, if different from 1(a):

Β 

(c)

Name of offeror/offeree in relation to whoseΒ relevant securities this form relates:

BLANCCO TECHNOLOGY GROUP PLC

(d)

If an exempt fund manager connected with anΒ offeror/offeree, state this and specify identity ofΒ offeror/offeree:

Β 

(e)

Date position held/dealing undertaken:

28 Sep 2023

(f)

In addition to the company in 1(c) above, is the discloser makingΒ disclosures in respect of any other party to the offer?

NO

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offereeΒ to which the disclosure relates following the dealing(if any)

Class of relevant security:

2p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

883,941

1.17%

1,692

0.00%

(2) Cash-settled derivatives:

1,692

0.00%

858,918

1.13%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:Β 

0

0.00%

0

0.00%

TOTAL:Β 

885,633

1.17%

860,610

1.14%

(b)

Rights to subscribe for new securities (including directors andΒ other executive options)

Class of relevant security in relation toΒ which subscription right exists

Details, including nature of the rightsΒ concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchase and sales

Class of relevantΒ security

Purchase/sale

Number ofΒ securities

Price per unit

2p ordinary

Purchase

30,987

2.2215 GBP

2p ordinary

Purchase

25,023

2.2222 GBP

(b)

Cash-settled derivative transactions

Class ofΒ relevantΒ security

Product description

Nature of dealing

Number ofΒ referenceΒ securities

Price perΒ unit

(c)

Stock-settled derivative transactionsΒ (including options)

(i)

Writing, selling, purchasing or varying

ClassΒ ofΒ relevantΒ security

ProductΒ description

Writing,Β purchasing,Β selling,Β varying etc

NumberΒ ofΒ securitiesΒ to whichΒ optionΒ relates

ExerciseΒ priceΒ per unit

Type

ExpiryΒ date

OptionΒ moneyΒ paid/Β receivedΒ per unit

(ii)

Exercising

Β 

Class of relevantΒ security

Product description

Exercising/ exercised against

Number ofΒ securities

Exercise price perΒ unit

(d)

Other dealings (including subscribing forΒ new securities)

Class of relevantΒ security

Nature of Dealings

Details

Price per unit (ifΒ applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,Β formal or informal, relating to relevant securities which may be an inducement to dealΒ or refrain from dealing entered into by the person making the disclosure and any partyΒ to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options orΒ derivatives

Details of any agreement, arrangement or understanding, formal or informal, betweenΒ the person making the disclosure and any other person relating to:Β (i) the voting rights of any relevant securities under any option; orΒ (ii) the voting rights of future acquisition or disposal of any relevant securities to whichΒ any derivative is referenced:

NONE

(c)

Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Oct 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETGPGWGUUPWGUM
Date   Source Headline
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
31st Oct 201212:06 pmRNSHolding(s) in Company
29th Oct 20127:00 amRNSRegenersis supports Samsung in new territory
12th Oct 20123:06 pmRNSHolding(s) in Company
12th Oct 201212:07 pmRNSHolding(s) in Company
11th Oct 20123:37 pmRNSHolding(s) in Company
11th Oct 201210:38 amRNSHolding(s) in Company
3rd Oct 20124:36 pmRNSHolding(s) in Company
3rd Oct 20122:20 pmRNSHolding(s) in Company
26th Sep 20129:43 amRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSFinal Results
12th Sep 20127:00 amRNSNotice of Analyst Briefing - Change of Date
4th Sep 20127:00 amRNSNotice of Results
31st Aug 20122:48 pmRNSCompletion of Acquisition and Issue of Equity
26th Jul 20127:00 amRNSTrading Update and Acquisition
18th Jun 20129:34 amRNSChange of Registered Office
11th Jun 20128:32 amRNSDirector/PDMR Shareholding
1st Jun 20124:07 pmRNSHolding(s) in Company
30th May 201210:03 amRNSDirector/PDMR Shareholding
10th May 20128:39 amRNSDirector/PDMR Shareholding
9th May 20123:30 pmRNSHolding(s) in Company
2nd May 20122:57 pmRNSDirector/PDMR Shareholding
19th Apr 201211:07 amRNSDirector/PDMR Shareholding
4th Apr 20121:08 pmRNSHolding(s) in Company
28th Mar 20122:48 pmRNSHolding(s) in Company
13th Mar 20127:00 amRNSHalf Yearly Report
7th Mar 20123:11 pmRNSBoard Change
29th Feb 20129:00 amRNSNotice of Results
27th Feb 20124:22 pmRNSHolding(s) in Company
8th Feb 20129:53 amRNSHolding(s) in Company
12th Jan 20127:01 amRNSBoard Change
12th Jan 20127:00 amRNSTrading Update
3rd Jan 20129:11 amRNSHolding(s) in Company
22nd Dec 201110:49 amRNSDirector/PDMR Shareholding
29th Nov 201112:57 pmRNSResult of AGM
29th Nov 201111:55 amRNSAGM Trading Update
7th Oct 20115:17 pmRNSDirector/PDMR Shareholding
7th Oct 20119:00 amRNSHolding(s) in Company
29th Sep 20111:00 pmRNSDirector/PDMR Shareholding
28th Sep 20119:50 amRNSReport and Accounts Published
28th Sep 20117:00 amRNSPreliminary Results
22nd Jul 201110:24 amRNSDirector/PDMR Shareholding
4th Jul 201111:18 amRNSDirector/PDMR Shareholding
4th Jul 20117:00 amRNSAppointment of Joint Broker
29th Jun 201111:53 amRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSTrading and Strategic Update
8th Jun 20119:03 amRNSDirector/PDMR Shareholding
31st May 20117:00 amRNSBusiness Update
23rd May 20114:19 pmRNSDirector/PDMR Shareholding
18th Mar 20117:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.